MIR192, microRNA 192, 406967

N. diseases: 173; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.310 Biomarker phenotype BEFREE It has been demonstrated that miR-122 and miR-192, which are liver enriched, could be potential biomarkers of DILI; however, these miRNAs cannot discern types of injuries. 30125006 2018
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.310 Biomarker phenotype CTD_human Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease. 28483554 2017
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.310 Biomarker phenotype CTD_human "Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human." 28545106 2017
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.310 Biomarker phenotype CTD_human Recently, circulating microRNAs (miRNAs) such as miR-122 and miR-192 have emerged as promising biomarkers of liver injury in preclinical species and in DILI patients. 25359176 2015
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.310 Biomarker phenotype CTD_human Circulating microRNAs as potential markers of human drug-induced liver injury. 22045675 2011